[
  {
    "ts": "2025-07-23T14:53:00+00:00",
    "headline": "Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?",
    "summary": "EXEL investors eye Cabometyx sales and zanzalintinib trial results ahead of Q2 earnings release on July 28.",
    "url": "https://finance.yahoo.com/news/exelixis-q2-earnings-cabometyx-sales-145300944.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "7030c1e9-3abf-35e8-91ab-97f23fce9a3d",
      "content": {
        "id": "7030c1e9-3abf-35e8-91ab-97f23fce9a3d",
        "contentType": "STORY",
        "title": "Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?",
        "description": "",
        "summary": "EXEL investors eye Cabometyx sales and zanzalintinib trial results ahead of Q2 earnings release on July 28.",
        "pubDate": "2025-07-23T14:53:00Z",
        "displayTime": "2025-07-23T14:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tj8ZNhTW.EaFq0gf4epBdA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m7FUnW0Rc7kH4rOUyfanWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exelixis-q2-earnings-cabometyx-sales-145300944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exelixis-q2-earnings-cabometyx-sales-145300944.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EXEL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]